BioSpace News Archive

Delcath Systems, Inc. announces that the Company granted an equity award, previously approved by the Company’s Compensation Committee, as a material inducement to the employment of one individual whose employment commenced in March 2024.

Simulations Plus, Inc., a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, announced that the U.S. FDA has renewed its licenses to the DILIsym® software platform.

Basilea Pharmaceutica Ltd, Allschwil announced that the US Food and Drug Administration approved ZEVTERA®, for the treatment of adult patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis, and adult patients with acute bacterial skin and skin structure infections and for adult and pediatric patients with community-acquired bacterial pneumonia.

EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, announced that the Company has completed its £27m funding round, supported by new and existing investors.

Grifols announced that its new Procleix ArboPlex Assay has obtained the CE mark under the In Vitro Diagnostic Regulation, the first for an automated nucleic acid test specifically validated for screening blood donors to detect four major arboviruses: chikungunya, dengue, West Nile and Zika viruses.

The Rare Cancer Research Foundation is proud to announce an exciting collaboration with Spanios aimed at propelling the discovery and validation of groundbreaking therapeutic options for rare cancers.

Exact Sciences, a leading provider of cancer screening and diagnostic tests, announced the launch of an initiative with Mayo Clinic to provide comprehensive genomic profiling and hereditary cancer tests to patients.

Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced that it has received 510 clearance from the U.S. Food and Drug Administration for the TEG® 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge.

ANI Pharmaceuticals, Inc. https://www.anipharmaceuticals.com/ is proud to support the Foundation for Sarcoidosis Research’s commitment to sarcoidosis patients and efforts to increase disease awareness during April’s Sarcoidosis Awareness Month.

Krystal Biotech, Inc. announced that the Company will be presenting new preclinical data on local and systemic immune activation following intratumoral injection of the Company’s platform technology encoding murine interleukin-12 and interleukin-2, the species matched equivalent to the Company’s clinical-stage oncology product candidate KB707, at the American Association for Cancer Research 2024 Annual Meeting being held from April 5-10, 2024 in San Diego, California.